Ambeed.cn

首页 / / / IDH / DS-1001b

DS-1001b {[allProObj[0].p_purity_real_show]}

货号:A1213617 同义名: DS-1001 Ambeed 开学季,买赠积分,赢豪礼

DS-1001b is a novel selective mutant IDH1 inhibitor with antitumor activity.

DS-1001b 化学结构 CAS号:1898207-64-1
DS-1001b 化学结构
CAS号:1898207-64-1
DS-1001b 3D分子结构
CAS号:1898207-64-1
DS-1001b 化学结构 CAS号:1898207-64-1
DS-1001b 3D分子结构 CAS号:1898207-64-1
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

DS-1001b 纯度/质量文件 产品仅供科研

货号:A1213617 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

JACS Au, 2024. Ambeed. [ A148168 ]
JMC, 2024. Ambeed. [ A187643 ]
JMC, 2024. Ambeed. [ A341145 , A633512 , A607865 , A167774 ]
Biomacromolecules, 2024. Ambeed. [ A110759 ]
Biomacromolecules, 2024. Ambeed. [ A203543 ]
更多 >

DS-1001b 生物活性

描述 Heterozygous mutations in genes encoding isocitrate dehydrogenase (IDH) 1 and 2 are frequently detected in acute myeloid leukemia (AML), angioimmunoblastic T-cell lymphoma, glioma, and cholangiocarcinoma. Mutant IDH catalyzes the formation of the oncometabolite D-2-hydroxyglutarate (D-2-HG). DS-1001b, a novel, orally bioavailable, selective mutant IDH1 inhibitor, impaired the proliferation of chondrosarcoma cells with IDH1 mutations in vitro and in vivo, and decreased 2-HG levels. Exposure to 1 μM DS-1001b for 72 h markedly decreased intracellular 2-HG levels in JJ012 and L835 cells. Intracellular D-2-HG levels were 100-fold higher than L-2-HG levels and completely blocked with 1 μM DS-1001b for 72 h in both IDH1-mutated cell lines. DS-1001b (0 - 10 μM) impaired proliferation in both cell lines in a dose-dependent manner. It decreased cell viability in a dose-dependent manner even under 3D and hypoxic conditions. Furthermore, treatment with different concentrations of DS-1001b for 72 h decreased intracellular 2-HG levels in a dose-dependent manner in JJ012 and L835 cells. In vivo, continuous administration of DS-1001b significantly impaired subcutaneous tumor growth in JJ012 xenograft mice. Moreover, 2-HG levels were markedly lower in DS-1001b-treated mice than in untreated mice (P < 0.001)[1].

DS-1001b 参考文献

[1]Nakagawa M, Nakatani F, Matsunaga H, et al. Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma. Oncogene. 2019;38(42):6835-6849

DS-1001b 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.64mL

0.33mL

0.16mL

8.21mL

1.64mL

0.82mL

16.42mL

3.28mL

1.64mL

DS-1001b 技术信息

CAS号1898207-64-1
分子式C29H29Cl3FN3O4
分子量 608.916
别名 DS-1001
运输蓝冰
存储条件

粉末 Inert atmosphere,2-8°C

液体 -20°C:3-6个月-80°C:12个月

溶解度

DMSO: 30 mg/mL(49.27 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。